The non-pathogenic Henipavirus Cedar paramyxovirus phosphoprotein has a compromised ability to target STAT1 and STAT2.

Abstract:

:Immune evasion by the lethal henipaviruses, Hendra (HeV) and Nipah virus, is mediated by its interferon (IFN) antagonist P gene products, phosphoprotein (P), and the related V and W proteins, which can target the signal transducer and activator of transcription 1 (STAT1) and STAT2 proteins to inhibit IFN/STAT signaling. However, it is not clear if the recently identified non-pathogenic Henipavirus, Cedar paramyxovirus (CedPV), is also able to antagonize the STAT proteins. We performed comparative studies between the HeV P gene products (P/V/W) and CedPV-P (CedPV does not encode V or W) and demonstrate that differences exist in their ability to engage the STAT proteins using immunoprecipitation and quantitative confocal microscopic analysis. In contrast to HeV-P gene encoded proteins, the ability of CedPV-P to interact with and relocalize STAT1 or STAT2 is compromised, correlating with a reduced capacity to inhibit the mRNA synthesis of IFN-inducible gene MxA. Furthermore, infection studies with HeV and CedPV demonstrate that HeV is more potent than CedPV in inhibiting the IFN-α-mediated nuclear accumulation of STAT1. These results strongly suggest that the ability of CedPV to counteract the IFN/STAT response is compromised compared to HeV.

journal_name

Antiviral Res

journal_title

Antiviral research

authors

Lieu KG,Marsh GA,Wang LF,Netter HJ

doi

10.1016/j.antiviral.2015.09.017

subject

Has Abstract

pub_date

2015-12-01 00:00:00

pages

69-76

eissn

0166-3542

issn

1872-9096

pii

S0166-3542(15)30017-6

journal_volume

124

pub_type

杂志文章
  • A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.

    abstract::Herpes simplex virus type-1 (HSV-1) causes significant health problems from periodic skin and corneal lesions to encephalitis. It is also considered a cofactor in the development of age-related secondary glaucoma. Inhibition of HSV-1 at the stage of viral entry generates a unique opportunity for preventative and/or th...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2009.07.014

    authors: Tiwari V,Shukla SY,Shukla D

    更新日期:2009-10-01 00:00:00

  • Germacrone inhibits early stages of influenza virus infection.

    abstract::Highly pathogenic influenza viruses pose a serious public health threat to humans. Although vaccines are available, antivirals are needed to efficiently control disease progression and virus transmission due to the emergence of drug-resistant viral strains. In this study, germacrone, which is a major component of the ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.09.021

    authors: Liao Q,Qian Z,Liu R,An L,Chen X

    更新日期:2013-12-01 00:00:00

  • Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method.

    abstract::We established a sensitive and accurate method for screening of anti-adenovirus agents using the 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. MKN-28 cells, which are well-differentiated stomach adenocarcinoma cells, were used for adenovirus (ADV) infection and examined for the anti-ADV act...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(96)06966-5

    authors: Kodama E,Shigeta S,Suzuki T,De Clercq E

    更新日期:1996-07-01 00:00:00

  • Inhibitory activity of the new adamantane derivative N,N'-bis(ethylene)-P(1-adamantyl)-phosphonic diamide against Rous sarcoma virus.

    abstract::A new adamantane derivative N,N'-bis (ethylene)P(1-adamantyl)-phosphonis diamide, was found to inhibit Rous sarcoma virus replication in much the same manner as reported for the parent compound, 1-adamantanamine hydrochloride. ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(81)90017-6

    authors: McGraw TL,Cates LA,Daley LS,Chen YC

    更新日期:1981-11-01 00:00:00

  • Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.

    abstract::Natural killer (NK) cells are a crucial component of the host innate immune system. We investigated the noncytolytic anti-human immunodeficiency virus (HIV) activity of NK cells in chronically HIV-infected immune cells. Supernatants collected from NK cell cultures (both primary NK cells and NK cell lines, YTS and NK 9...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2006.08.006

    authors: Zhang T,Li Y,Wang YJ,Wang X,Young M,Douglas SD,Ho WZ

    更新日期:2007-02-01 00:00:00

  • Semi-quantitative detection of viral RNA in influenza A virus-infected mice for evaluation of antiviral compounds.

    abstract::The aim of the study was to establish a murine model for sensitive screening of potential compounds with in vitro anti-influenza A virus activity. The evaluation in this in vivo model is based on semi-quantitative detection of viral RNA using one-step reverse transcriptase polymerase chain reaction (RT-PCR). After int...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(02)00184-5

    authors: Sauerbrei A,Ulbricht A,Wutzler P

    更新日期:2003-03-01 00:00:00

  • Baculovirus AcMNPV induces type I interferons and NK/NKT cells-mediated protection against foot-and-mouth disease virus in mice.

    abstract::Foot-and-mouth disease is a viral illness that affects cloven-hoofed animals causing serious economic losses. Inactivated vaccines against its causative agent, foot-and-mouth disease virus (FMDV), require approximately seven days to induce protection. Therefore, antiviral strategies are needed to provide earlier prote...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104850

    authors: Molina GN,Cacciabue M,Gismondi MI,Taboga O,Molinari P

    更新日期:2020-08-01 00:00:00

  • Identification of quinolone derivatives as effective anti-Dengue virus agents.

    abstract::Dengue virus (DENV) infection is one of the most important infectious diseases in tropical and subtropical regions around the world. Previously, we performed an initial phenotypic screening of 7000 compounds using DENV type 2 (DENV2)-infected BHK-21 cells to identify small molecules which could inhibit virus replicati...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104969

    authors: Nobori H,Uemura K,Toba S,Sanaki T,Shishido T,Hall WW,Orba Y,Sawa H,Sato A

    更新日期:2020-12-01 00:00:00

  • A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication.

    abstract::The human pathogen hepatitis C virus (HCV) is associated with chronic liver disease. The recent development of the cell culture infectious HCV (HCVcc) system has opened up avenues for detailed studies on the life cycle of the virus and its interaction with the host cell. Current methods to quantitate virus infectivity...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2009.04.007

    authors: Iro M,Witteveldt J,Angus AG,Woerz I,Kaul A,Bartenschlager R,Patel AH

    更新日期:2009-08-01 00:00:00

  • Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection.

    abstract::Favipiravir (T-705) is a broad spectrum antiviral which has been approved in Japan for the treatment of severe influenza virus infections. We reported earlier that favipiravir inhibits the in vitro replication of CHIKV and protects against disease progression in CHIKV-infected immunodeficient mice. We here explored wh...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2017.09.016

    authors: Abdelnabi R,Jochmans D,Verbeken E,Neyts J,Delang L

    更新日期:2018-01-01 00:00:00

  • Effect of cyclosporin A on the production of interferon by human peripheral blood leukocytes in vitro.

    abstract::Cyclosporin A (CsA) was assessed for its effect on the production of antiviral activity by human peripheral blood leukocytes (PBL). CsA markedly reduced the production of interferon-gamma (IFN-gamma) in response to stimulation with lectin mitogens, bacterial products, alloantigens, or Epstein-Barr virus (EBV)-transfor...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(82)90006-7

    authors: Abb J,Abb H,Deinhardt F

    更新日期:1982-12-01 00:00:00

  • The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding.

    abstract::The bicyclams represent a new class of highly potent and selective HIV inhibitors. Time-of-addition experiments have previously shown that these compounds interfere with an early event in the viral replicative cycle. Additional experiments have now been carried out in order to investigate in more detail the mechanism ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(95)00837-3

    authors: De Vreese K,Reymen D,Griffin P,Steinkasserer A,Werner G,Bridger GJ,Esté J,James W,Henson GW,Desmyter J,Anné J,De Clercq I

    更新日期:1996-03-01 00:00:00

  • Combined antiviral options for the treatment of chronic hepatitis C.

    abstract::In the absence of antiviral treatment, chronic hepatitis C virus (HCV) infection is a liver disease characterized by the development of necroinflammatory changes and progressive liver fibrosis, leading to cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC). The approval of ribavirin in combination th...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2003.08.009

    authors: Medina J,García-Buey L,Moreno-Monteagudo JA,Trapero-Marugán M,Moreno-Otero R

    更新日期:2003-10-01 00:00:00

  • Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options.

    abstract::An estimated 15-20 million individuals are co-infected by hepatitis B and hepatitis D virus worldwide and are at high risk of developing end-stage liver disease, including hepatocellular carcinoma. While HBV viremia can now be controlled in the vast majority of individuals by nucleoside analogs, leading to a delay of ...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2015.08.009

    authors: Alfaiate D,Dény P,Durantel D

    更新日期:2015-10-01 00:00:00

  • Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners.

    abstract::Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA), the stable genomic form as the template for viral transcription, plays a crucial role in viral persistence which remains a major global health problem. While accumulating evidence suggests the involvement of transcription factors and epigenetic machinery...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2018.03.008

    authors: Xu L,Wu Z,Tan S,Wang Z,Lin Q,Li X,Song X,Liu Y,Song Y,Zhang J,Peng J,Gao L,Gong Y,Liang X,Zuo X,Ma C

    更新日期:2018-05-01 00:00:00

  • Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option?

    abstract::The replication cycle of the human cytomegalovirus (HCMV) is characterized by the expression of immediate early (IE), early (E), and late (L) gene regions. Current antiviral strategies are directed against the viral DNA polymerase expressed during the early phase of infection. The regulation of the IE-1 and IE-2 gene ...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/s0166-3542(01)00126-7

    authors: Scholz M,Doerr HW,Cinatl J

    更新日期:2001-03-01 00:00:00

  • Antiviral activity of S-adenosylhomocysteine hydrolase inhibitors against plant viruses.

    abstract::Three SAH hydrolase inhibitors, (RS)-3-adenin-9-yl-2-hydroxypropanoic acid (isobutyl ester) [(RS)-AHPA]; (RS)-9-(2,3-dihydroxypropyl)adenine [(RS)-DHPA] and the carbocyclic analog of 3-deazaadenosine (C-c3Ado) were evaluated for their inhibitory activity against tobacco mosaic virus (TMV) and potato virus X (PVX). Usi...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(90)90067-h

    authors: De Fazio G,Alba AP,Vicente M,De Clercq E

    更新日期:1990-05-01 00:00:00

  • Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency.

    abstract::Suberoylanilide hydroxamic acid (SAHA) has been assessed in clinical trials as part of a "shock and kill" strategy to cure HIV-infected patients. While it was effective at inducing expression of HIV RNA ("shock"), treatment with SAHA did not result in a reduction of reservoir size ("kill"). We therefore utilized a com...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2015.09.002

    authors: White CH,Johnston HE,Moesker B,Manousopoulou A,Margolis DM,Richman DD,Spina CA,Garbis SD,Woelk CH,Beliakova-Bethell N

    更新日期:2015-11-01 00:00:00

  • Gamma secretase inhibition impairs HCMV replication by reduction of immediate early gene expression at the transcriptional level.

    abstract::Due to diverse pathogenic potentials, there is a growing need for anti-HCMV agents. In this study, we show that treatment with DAPT, a γ-secretase inhibitor (GSI), impairs HCMV replication as assessed by a progeny assay based on immunostaining. This effect is not limited to DAPT because other GSIs with different struc...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104867

    authors: Lee SM,Han D,Kwon M,Noh H,Lee JH,Yoon Y,Cho JY,Ahn JH,Yoon K

    更新日期:2020-11-01 00:00:00

  • Derivatives of amphotericin inhibit infection with human immunodeficiency virus in vitro by different modes of action.

    abstract::Three water-soluble derivatives of amphotericin B were tested for inhibition of HIV infection in vitro. The compounds amphotericin B methyl ester (AME) and N-(N'-(2-(4'-methylmorpholinio)ethyl)N"-cyclohexyl guanyl) amphotericin B methyl ester (MCG) inhibited HIV infection by 50% at 1 microgram/ml; N-(N'-(3-dimethylami...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(90)90031-2

    authors: Hansen JE,Witzke NM,Nielsen C,Mathiesen LR,Teglbjaerg LS,Nielsen CM,Nielsen JO

    更新日期:1990-09-01 00:00:00

  • Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

    abstract::The emergence of multidrug-resistant influenza viruses poses a persistent threat to public health. The current prophylaxis and therapeutic interventions for influenza virus infection have limited efficacy due to the continuous antigenic drift and antigenic shift of influenza viruses. As part of our ongoing effort to d...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2017.07.016

    authors: Hu Y,Zhang J,Musharrafieh RG,Ma C,Hau R,Wang J

    更新日期:2017-09-01 00:00:00

  • Nanobodies®: new ammunition to battle viruses.

    abstract::In 1989, a new type of antibody was identified, first in the sera of dromedaries and later also in all other species of the Camelidae family. These antibodies do not contain a light chain and also lack the first constant heavy domain. Today it is still unclear what the evolutionary advantage of such heavy chain-only a...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2011.09.002

    authors: Vanlandschoot P,Stortelers C,Beirnaert E,Ibañez LI,Schepens B,Depla E,Saelens X

    更新日期:2011-12-01 00:00:00

  • Effect of antiviral treatment in older patients hospitalized with confirmed influenza.

    abstract::Seasonal influenza causes significant morbidity and mortality in people aged ≥65 years. Antiviral treatment can reduce complications and disease severity. The objective of this study was to investigate the effect of antiviral treatment in patients aged ≥65 years hospitalized with confirmed influenza in preventing inte...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2020.104785

    authors: Soldevila N,Toledo D,Ortiz de Lejarazu R,Tamames S,Castilla J,Astray J,Fernández MA,Martín V,Egurrola M,Morales Suárez-Varela M,Domínguez À,Working Group of Project PI12\/02079.

    更新日期:2020-06-01 00:00:00

  • Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.

    abstract::Foot and mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals. Previously, we found that the epitope peptide EP141-160 displayed on virus-like particles (VLP) for use as a vaccine showed high immunoreactivity and conferred partially effective protection to animals. In this study, we first ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.08.020

    authors: Dong YM,Cai JC,Chen HT,Chen L

    更新日期:2016-10-01 00:00:00

  • Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains.

    abstract::Previously, we found that a ganciclovir (GCV)-resistant clinical human cytomegalovirus (HCMV) isolate had an amino acid substitution at codon 501 (Leu --> Phe) in the delta-region C of the DNA polymerase gene. DNA polymerases have now been (partially) purified from both the GCV-resistant and sensitive parental strains...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/s0166-3542(00)00063-2

    authors: Kariya M,Mori S,Eizuru Y

    更新日期:2000-02-01 00:00:00

  • Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions.

    abstract::We report the design, synthesis, and biological evaluation of a class of 1H-pyrido[2,1-b][1,3]benzothiazol-1-ones originated from compound 1, previously identified as anti-flavivirus agent. Some of the new compounds showed activity in low μM range with reasonable selectivity against Dengue 2, Yellow fever (Bolivia str...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2019.03.004

    authors: Cannalire R,Tarantino D,Piorkowski G,Carletti T,Massari S,Felicetti T,Barreca ML,Sabatini S,Tabarrini O,Marcello A,Milani M,Cecchetti V,Mastrangelo E,Manfroni G,Querat G

    更新日期:2019-07-01 00:00:00

  • In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.

    abstract::Natural products provide a large reservoir of potentially active agents with anti-hepatitis B virus (HBV) activity. We examined the effect of the polyphenolic extract from Geranium carolinianum L. (PPGC) on HBV replication both in vitro and in vivo. In the human HBV-transfected liver cell line HepG(2) 2.2.15, PPGC eff...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2008.03.001

    authors: Li J,Huang H,Feng M,Zhou W,Shi X,Zhou P

    更新日期:2008-08-01 00:00:00

  • A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.

    abstract::Sequences from the gag, pol and rev regions of the RF strain of HIV-1 (HIV-1RF) were chosen as targets for antisense phosphorothioate oligodeoxynucleotides (S-oligos). These sequences were the p18/p24 junction in gag, the active site of HIV protease in pol; a sequence from the first exon of the rev gene and S-oligodeo...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(92)90090-r

    authors: Kinchington D,Galpin S,Jaroszewski JW,Ghosh K,Subasinghe C,Cohen JS

    更新日期:1992-01-01 00:00:00

  • Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial.

    abstract:BACKGROUND AND AIMS:Interferon-alpha treatment has been the treatment of choice for chronic hepatitis with unpredictable results. Recently, Lamivudine has been licensed for use against HBV infection with good results. Unfortunately, recurrence of viremia after lamivudine withdrawal is common and prolonged treatment can...

    journal_title:Antiviral research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0166-3542(00)00141-8

    authors: Andreone P,Fiorino S,Cursaro C,Gramenzi A,Margotti M,Di Giammarino L,Biselli M,Miniero R,Gasbarrini G,Bernardi M

    更新日期:2001-02-01 00:00:00

  • Animal models of Middle East respiratory syndrome coronavirus infection.

    abstract::The emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 marked the second time that a new, highly pathogenic coronavirus has emerged in the human population in the 21st century. In this review, we discuss the current state of knowledge of animal models of MERS-CoV infection. Commonly used ...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2015.07.005

    authors: van Doremalen N,Munster VJ

    更新日期:2015-10-01 00:00:00